NCT02155842

Brief Summary

The purpose of this study is to determine whether endurance exercise of either high or moderate intensity can reverse structural and functional changes of the heart in patients with diastolic heart failure, and to investigate which type of exercise is best in terms of aerobe capacity and quality of life. The investigators expect that high intensity endurance exercise is superior to moderate intensity endurance exercise.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2014

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2014

Completed
5 days until next milestone

Study Start

First participant enrolled

June 1, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 4, 2014

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

March 30, 2016

Status Verified

March 1, 2016

Enrollment Period

1.5 years

First QC Date

May 27, 2014

Last Update Submit

March 29, 2016

Conditions

Keywords

exercise therapy

Outcome Measures

Primary Outcomes (1)

  • Change in aerobic capacity measured as oxygen consumption

    Cardiopulmonary exercise test

    Baseline and 7 months

Secondary Outcomes (7)

  • Feasibility, measured as attrition rate and compliance with exercise

    Baseline to 7 months

  • Blood-risk profile, measured as changes in cholesterol, hemoglobin, N terminal-proBNP

    Baseline to 7 months

  • Cardiac function measured as volume, size, efficacy

    Baseline to 7 months

  • Arterial function measured as blood-vessel elasticity

    Baseline to 7 months

  • Quality of life

    Baseline to 7 months

  • +2 more secondary outcomes

Study Arms (2)

High intensity endurance exercise

EXPERIMENTAL

Four weeks comprehensive cardiac rehabilitation with moderate volume high intensity endurance exercise, followed by 6 months non-supervised endurance exercise

Behavioral: High intensity endurance exercise

Moderate continuous endurance exercise

ACTIVE COMPARATOR

Four weeks comprehensive cardiac rehabilitation with moderate volume moderate intensity endurance exercise, followed by 6 months non-supervised endurance exercise

Behavioral: Moderate continuous endurance exercise

Interventions

High intensity endurance exercise
Moderate continuous endurance exercise

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sedentary lifestyle
  • Normal systolic function left ventricular ejection fraction (LVEF) \< 50%
  • New York Heart Association (NYHA) class II or III
  • Diastolic dysfunction (E/é \< 15 or E/é 8-15 and N-terminal proBNP \> 220pg/ml)
  • Medically stable the last 4 weeks
  • Written informed consent

You may not qualify if:

  • Other causes of dyspnea than diastolic heart failure
  • Personal preferences or characteristics prohibiting the person from attending inpatient cardiac rehabilitation
  • Not able to perform physical exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

LHL Klinikkene

Røros, Norway

Location

MeSH Terms

Conditions

Heart Failure, DiastolicVentricular Dysfunction, Left

Condition Hierarchy (Ancestors)

Heart FailureHeart DiseasesCardiovascular DiseasesVentricular Dysfunction

Study Officials

  • Ulrik Wisløff, phd prof

    Norwegian University of Science and Technology

    STUDY DIRECTOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2014

First Posted

June 4, 2014

Study Start

June 1, 2014

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

March 30, 2016

Record last verified: 2016-03

Data Sharing

IPD Sharing
Will not share

Locations